Turkish Journal of Hematology最新文献

筛选
英文 中文
Analysis of Hereditary FXII Deficiency Caused by Three Mutations Including a Novel Mutation 分析由三种突变(包括一种新型突变)引起的遗传性 FXII 缺乏症
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 Epub Date: 2024-02-01 DOI: 10.4274/tjh.galenos.2024.2024.0016
Longying Ye, Meina Liu, Lihong Yang, Mingshan Wang, Yaosheng Xie
{"title":"Analysis of Hereditary FXII Deficiency Caused by Three Mutations Including a Novel Mutation","authors":"Longying Ye, Meina Liu, Lihong Yang, Mingshan Wang, Yaosheng Xie","doi":"10.4274/tjh.galenos.2024.2024.0016","DOIUrl":"10.4274/tjh.galenos.2024.2024.0016","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"66-68"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139651778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Many Faces of Multiple Myeloma 多发性骨髓瘤的多面性
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 Epub Date: 2023-08-04 DOI: 10.4274/tjh.galenos.2023.2023.0183
Asya Tuğçe Bol, Güldane Cengiz Seval, Meral Beksaç, Işınsı Kuzu
{"title":"The Many Faces of Multiple Myeloma","authors":"Asya Tuğçe Bol, Güldane Cengiz Seval, Meral Beksaç, Işınsı Kuzu","doi":"10.4274/tjh.galenos.2023.2023.0183","DOIUrl":"10.4274/tjh.galenos.2023.2023.0183","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"41-42"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9937502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating Monocytes Phagocytosing Lymphocytes in the Small-Cell Variant of T-Cell Prolymphocytic Leukemia T细胞前淋巴细胞白血病小细胞变异中吞噬淋巴细胞的循环单核细胞
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 Epub Date: 2023-12-28 DOI: 10.4274/tjh.galenos.2023.2023.0422
Shuai Zhang, Meng Ma, Yanping Liu, Ying Bu, Zhe Zhang, Yun Zhang
{"title":"Circulating Monocytes Phagocytosing Lymphocytes in the Small-Cell Variant of T-Cell Prolymphocytic Leukemia","authors":"Shuai Zhang, Meng Ma, Yanping Liu, Ying Bu, Zhe Zhang, Yun Zhang","doi":"10.4274/tjh.galenos.2023.2023.0422","DOIUrl":"10.4274/tjh.galenos.2023.2023.0422","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"53-54"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918400/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139049410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunoglobulin Replacement Therapy for Hypogammaglobulinemia in Multiple Myeloma Should Not Be Ignored 不要忽视免疫球蛋白替代疗法治疗多发性骨髓瘤患者的低丙种球蛋白血症。
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 Epub Date: 2024-01-04 DOI: 10.4274/tjh.galenos.2024.2023.0401
Qinggang Zhang, Yongliang Wang, Wei Pan
{"title":"Immunoglobulin Replacement Therapy for Hypogammaglobulinemia in Multiple Myeloma Should Not Be Ignored","authors":"Qinggang Zhang, Yongliang Wang, Wei Pan","doi":"10.4274/tjh.galenos.2024.2023.0401","DOIUrl":"10.4274/tjh.galenos.2024.2023.0401","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"51-52"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139088739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of Rare Gene Alterations in the Prognosis of B-Cell Acute Lymphoblastic Leukemia 罕见基因对 B 细胞急性淋巴细胞白血病预后的重要性。
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 Epub Date: 2024-01-04 DOI: 10.4274/tjh.galenos.2024.2023.0400
Li Xiang, Yongliang Wang, Wei Pan
{"title":"Importance of Rare Gene Alterations in the Prognosis of B-Cell Acute Lymphoblastic Leukemia","authors":"Li Xiang, Yongliang Wang, Wei Pan","doi":"10.4274/tjh.galenos.2024.2023.0400","DOIUrl":"10.4274/tjh.galenos.2024.2023.0400","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"49-50"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139088741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rifampicin-Induced Toxic Hepatitis in a Patient with Hemophilia After Chemical Synovectomy 一名血友病患者在化学滑膜切除术后因利福平诱发中毒性肝炎。
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 Epub Date: 2024-02-07 DOI: 10.4274/tjh.galenos.2024.2023.0420
Mehmet Can Uğur, Semih Aydoğdu, Elçil Kaya Biçer, Can Balkan, Kaan Kavaklı
{"title":"Rifampicin-Induced Toxic Hepatitis in a Patient with Hemophilia After Chemical Synovectomy","authors":"Mehmet Can Uğur, Semih Aydoğdu, Elçil Kaya Biçer, Can Balkan, Kaan Kavaklı","doi":"10.4274/tjh.galenos.2024.2023.0420","DOIUrl":"10.4274/tjh.galenos.2024.2023.0420","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"64-65"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918404/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139698356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients. CALR和JAK2V617F突变对重要血小板增多症临床过程和疾病结局的影响:土耳其患者的多中心回顾性研究。
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 DOI: 10.4274/tjh.galenos.2024.2023.0430
Zehra Narlı Özdemir, Yıldız İpek, Püsem Patır, Gözde Ermiş, Rafiye Çiftçiler, Deniz Özmen, Mehmet Baysal, Vildan Gürsoy, Esra Yıldızhan, Serkan Güven, Tarık Ercan, Tayfun Elibol, Sinan Mersin, Eylem Genç, Eren Arslan Davulcu, Volkan Karakuş, Nergiz Erkut, Gürsel Güneş, Reyhan Diz Küçükkaya, Ahmet Emre Eşkazan
{"title":"Impact of <i>CALR</i> and <i>JAK2</i>V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.","authors":"Zehra Narlı Özdemir, Yıldız İpek, Püsem Patır, Gözde Ermiş, Rafiye Çiftçiler, Deniz Özmen, Mehmet Baysal, Vildan Gürsoy, Esra Yıldızhan, Serkan Güven, Tarık Ercan, Tayfun Elibol, Sinan Mersin, Eylem Genç, Eren Arslan Davulcu, Volkan Karakuş, Nergiz Erkut, Gürsel Güneş, Reyhan Diz Küçükkaya, Ahmet Emre Eşkazan","doi":"10.4274/tjh.galenos.2024.2023.0430","DOIUrl":"10.4274/tjh.galenos.2024.2023.0430","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we investigated the effects of calreticulin (<i>CALR</i>) and <i>JAK2</i>V617F mutational status on clinical course and disease outcomes in Turkish patients with essential thrombocythemia (ET).</p><p><strong>Materials and methods: </strong>Seventeen centers from Türkiye participated in the study and <i>CALR</i>- and <i>JAK2</i>V617F-mutated ET patients were evaluated retrospectively.</p><p><strong>Results: </strong>A total of 302 patients were included, of whom 203 (67.2%) and 99 (32.8%) were <i>JAK2</i>V617F- and <i>CALR</i>-positive, respectively. <i>CALR</i>-mutated patients were significantly younger (51 years vs. 57.5 years, p=0.03), with higher median platelet counts (987x10<sup>9</sup>/L vs. 709x10<sup>9</sup>/L, p<0.001) and lower median hemoglobin levels (13.1 g/dL vs. 14.1 g/dL, p<0.001) compared to <i>JAK2</i>V617F-mutated patients. Thromboembolic events (TEEs) occurred in 54 patients (17.9%), 77.8% of which were arterial. Compared to <i>CALR</i> mutation, <i>JAK2</i>V617F was associated with a higher risk of thrombosis (8.1% vs. 22.7%, p=0.002). Rates of transformation to myelofibrosis (MF) and leukemia were 4% and 0.7%, respectively, and these rates were comparable between <i>JAK2</i>V617F- and <i>CALR</i>-mutated cases. The estimated overall survival (OS) and MF-free survival of the entire cohort were 265.1 months and 235.7 months, respectively. OS and MF-free survival durations were similar between <i>JAK2</i>V617F- and <i>CALR</i>-mutated patients. Thrombosis-free survival (TFS) was superior in <i>CALR</i>-mutated patients compared to <i>JAK2</i>V617F-positive patients (5-year TFS: 90% vs. 71%, respectively; p=0.001). Age at diagnosis was an independent factor affecting the incidence of TEEs.</p><p><strong>Conclusion: </strong>In our ET cohort, <i>CALR</i> mutations resulted in higher platelet counts and lower hemoglobin levels than <i>JAK2</i>V617F and were associated with younger age at diagnosis. <i>JAK2</i>V617F was strongly associated with thrombosis and worse TFS. Hydroxyurea was the most preferred cytoreductive agent for patients with high thrombosis risk.</p>","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":"41 1","pages":"26-36"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiphospholipid Syndrome: To Classify or Not to Classify? 抗磷脂综合征:分类还是不分类?
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 Epub Date: 2024-01-29 DOI: 10.4274/tjh.galenos.2024.2024.0003
Doruk Erkan
{"title":"Antiphospholipid Syndrome: To Classify or Not to Classify?","authors":"Doruk Erkan","doi":"10.4274/tjh.galenos.2024.2024.0003","DOIUrl":"10.4274/tjh.galenos.2024.2024.0003","url":null,"abstract":"<p><p>Antiphospholipid syndrome (APS) is a systemic autoimmune disorder resulting in thrombosis, microvascular disease, morbidity in pregnancy, and/or non-thrombotic manifestations. The recently introduced 2023 American College of Rheumatology (ACR) and European Alliance of Associations for Rheumatology (EULAR) APS classification criteria, with significantly higher specificity compared to the revised Sapporo criteria, now reflect the current thinking about APS and provide a new foundation for future APS research. The purpose of this short commentary is to discuss the appropriate circumstances under which the 2023 ACR/EULAR classification criteria could be used and to demonstrate how the new criteria can be applied to simple case scenarios.</p>","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"37-40"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918394/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139570892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction 成功治疗一名慢性淋巴细胞白血病患者伊布替尼诱发的血小板减少症:不中断,只减少。
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 Epub Date: 2023-12-22 DOI: 10.4274/tjh.galenos.2023.2023.0426
Simge Erdem, Meliha Nalçacı
{"title":"Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction","authors":"Simge Erdem, Meliha Nalçacı","doi":"10.4274/tjh.galenos.2023.2023.0426","DOIUrl":"10.4274/tjh.galenos.2023.2023.0426","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"55-56"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138831697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia. 一名慢性淋巴细胞白血病患者的伊布替尼相关白细胞坏死性血管炎
IF 2.6 4区 医学
Turkish Journal of Hematology Pub Date : 2024-03-01 DOI: 10.4274/tjh.galenos.2023.2023.0368
Ayşe Kaya, İbrahim Aras, Pervin Özkan Kurtgöz, Umut Çakıroğlu
{"title":"Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia.","authors":"Ayşe Kaya, İbrahim Aras, Pervin Özkan Kurtgöz, Umut Çakıroğlu","doi":"10.4274/tjh.galenos.2023.2023.0368","DOIUrl":"10.4274/tjh.galenos.2023.2023.0368","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":"41 1","pages":"57-58"},"PeriodicalIF":2.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信